Insider Transactions Reported by 24 Insiders of Jasper Therapeutics, Inc.

Symbol
JSPR, JSPRW on Nasdaq
Location
Redwood City, CA

Insiders trading volume in the past year

Jasper Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Velan Capital Investment Management LP 10%+ Owner $18,568,073 08 Feb 2024
Carlyle Group Inc. Former 10% Owner $13,807,148 08 Feb 2024
Qiming U.S. Healthcare Fund II, L.P. 10%+ Owner $5,525,844 27 Jan 2023
ROCHE HOLDING LTD 10%+ Owner $2,950,874 25 Jan 2023
BALAJI VENKATARAMAN Former Director And Officer $1,491,780 24 Sep 2021
HOWARD I. HOFFEN Former Director $1,491,780 24 Sep 2021
Amplitude Healthcare Holdings LLC 10%+ Owner $1,491,780 24 Sep 2021
Kenneth F. Clifford Former Officer $1,491,780 24 Sep 2021
Judith Anne Shizuru Director $381,269 +$99,630 +35% 22 Sep 2025
RON MARTELL President, CEO and Director, Director $180,106 +$99,630 +124% 02 Jan 2026
THOMAS G. WIGGANS Director $113,830 +$99,630 +702% 22 Sep 2025
Svetlana Lucas Director $48,600 +$48,600 22 Sep 2025
William Lis Director $34,714 13 Oct 2023
Edwin Jonathan Tucker Chief Medical Officer $1,669 04 Jun 2025
Chris Nolet Director 03 Jul 2025
Herb Cross Chief Financial Officer 02 Jan 2026
Kevin N. Heller Executive Vice President, Research and Development 21 Mar 2022
EMSTER KURT VON Director 03 Jul 2025
Anna Louise French Director 06 Jun 2024
Abingworth LLP 10%+ Owner 21 Mar 2022
Lawrence Otto Klein Director 07 Jun 2023
Jeetinder Singh Mahal CEO and President, Director 06 Feb 2026
Vishal Kapoor Director 03 Jul 2025
Scott C. Brun Director 03 Jul 2025

Recent Insider Transactions by Companies or Individuals for Jasper Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.